Stéphane Bancel, Moderna CEO (Charles Krupa/AP Images)

Up­dat­ed: Mod­er­na claims can­cer vac­cine suc­cess in tri­al of mR­NA shot with Mer­ck

An ex­per­i­men­tal, mR­NA-based can­cer vac­cine sig­nif­i­cant­ly re­duced the risk that melanoma pa­tients’ can­cers would re­turn and be fa­tal, Mod­er­na and Mer­ck said, in what the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.